EumovateTM (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety

References

• McKenzie AW, Stoughton RB, Method for comparing percutaneous absorption of steroids. Arch Dermatol (1962) 86: 88–90.
   Google Scholar
• Wilson L, The clinical assessment of topical corticoster- oid activity. British Journal of Dermatology (1976) 94 (suppl 12): 33–42.
   Google Scholar
• Neame R, Berth-Jones J, How to get the best from topical corticosteroids. Prescriber 1994; 25–30.
   Google Scholar
• Seidenari S, di Nardo A, Mantovani L, Gianetti A, Parallel intra-individual evaluation of the vasoconstric- tory action and the anti-allergic activity of topical corticosteroids. Exp Dermatol (1997) 6(2): 75–80.
   PubMedGoogle Scholar
• Aggerwal A, Maddin S, Alclometasone dipropionate in psoriasis: a clinical study. Journal of International Medical Research (1982) 10(6): 414–418.
   PubMed Web of Science ®Google Scholar
• Allenby CF, Sparkes CG, Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases. British Journal of Dermatology (1981) 104(2): 179–183.
   PubMed Web of Science ®Google Scholar
• Beconcini D, Cristiani G, Mian E, et al, Various formulations of topical clobetasone butyrate in the treatment of dermatitis. Current Therapeutic Research (1990) 48(1): 69–79.
   Web of Science ®Google Scholar
• Bigliardi P, Eumovate in dermatological practice: study of a new topical corticosteroid. Therapeutische Umschau (1984) 41(6): 425–428.
   PubMed Web of Science ®Google Scholar
• Bonavita E, Bassi R, Mengoni M, Clobetasone butyrate, a topical steroid, in geriatrics. Clinical Terapeutica (1985[a]) 112(5): 423–428.
   Google Scholar
• Bonavita E, Chioma V, Mengoni M, Fini C, Clinical observation on the use of clobetasone butyrate in old patients’ dermatitis. Giornale di Gerontologia (1985[b]) 32(8): 675–683.
   Google Scholar
• Boner AL, Richelli C, De Stefano G, Antonini I, Aprili F, Mengoni M, Adrenocortical function during prolonged treatment with cronic atopic dermatitis and elevated IgE levels. Int J Clin Pharm Res. (1985[a]) V(2): 127–131.
   Google Scholar
• Boner AL, Richelli C, De Stefano G, et al, Hypothalamic- pituitary-adrenal function in children with atopic derma- titis treated with clobetasone butyrate and its clinical evaluation. International Journal of Clinical Pharmacology. Therapy and Toxicology (1985[b]) 23(2): 118–120.
   Google Scholar
• Caramia G, Bizzarri V, Gregorini S, et al, Current aspects of topical steroid therapy in non-infectious dermatitis in infants. Current Therapeutic Research (1985) 37(2): 213–224.
   Web of Science ®Google Scholar
• Carmineo L, Rantuccio F, Clinical study on the subject of the therapeutic activity of a new topical steroid; clobetasone butyrate. Chronica Dermatologica (1983) 1: 75–81.
   Google Scholar
• Clinical Research Group for clobetasone 17 butyrate, A double blind controlled study on the clinical efficacy of topical clobetasone 17 butyrate. Nishinihon Journal of Dermatology (1981) 43(1): 124–131.
   Google Scholar
• Dominguez L, Hojyo T, Vega E, et al, Comparison of the safety and efficacy of mometasone furoate cream 0.1% and clobetasone butyrate cream 0.05% in the treatment of children with a variety of dermatoses. Current Therapeutic Research (1990) 48(1): 128–139.
   Web of Science ®Google Scholar
• Duke EE, Maddin S, Aggerwal A, Alclometasone dipropionate in atopic dermatitis: a clinical study. Current Therapeutic Research (1983) 33(5): 769–774.
   Web of Science ®Google Scholar
• Fallica L, Gallone C, Gasparri O, Mengoni M, Clobeta- sone butyrate in the treatment of some cases of con- tact dermatitis. Clinical Trials Journal (1985) 22(2): 129–134.
   Google Scholar
• Frefriksson T, Nordin K, Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis: Current Medical Research and Opinion 1979; 6(5): 322–324.
   PubMed Web of Science ®Google Scholar
• Gibson JR, Kirsch JM, Darley CR, et al, An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations. British Journal of Dermatology (1984) 111 (suppl 27): 204–212.
   Google Scholar
• Graber, Miescher A, Schneider HJ, Eumovate in paediatric practice. Swiss study of a new topical corticosteroid. Therapeutische Umschau (1983) 40(5): 449–453.
   PubMedGoogle Scholar
• Lassus A, Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double- blind comparison. Current Medical Research and Opinion (1979) 6(3): 165–167.
   PubMed Web of Science ®Google Scholar
• Lassus A, Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%: a controlled clinical comparison in the treatment of atopic dermatitis in children. International Journal of Dermatology (1984) 23(8): 565–566.
   PubMed Web of Science ®Google Scholar
• Lowy G, Double-blind study with clobetasone 17 butyrate and fluocinolone on corticosteroid-responsive symmetrical dermatoses. Farmacologia Medica (1979) 78(6): 581–584.
   Google Scholar
• Marson G, Clinical trial of a new topical steroid preparation; clobetasone butyrate. Chronica Dermatolo- gica (1985) 16(5): 717–725.
   Google Scholar
• Morley N, Fry L, Walker S, Clinical evaluation of clobetasone butyrate in the treatment of children with atopic eczema, and its effects on plasma corticosteroid levels. Current Medical Research and Opinion (1976) 4(3): 223–228.
   PubMedGoogle Scholar
• Muller W, Neuman Y, Alclometasone, a new topical steroid. Therapiewoche (1985) 35(9): 942–948.
   Google Scholar
• Pagnes P, Investigation of the topical activity and systemic absorption of a new topical corticosteroid: clobetasone butyrate. Chronica Dermatologica (1984) 15(5): 735–741.
   Google Scholar
• Peroni A, Nigro M, Schena D, Clobetasone butyrate (Eumovate) in dermatological practice. Clinical Trials Journal (1985) 22(4): 373–380.
   Google Scholar
• Porto JA, Da Providencia Coelho Braga M, Double-blind study of clobetasone 17 butyrate and fluocinolone in topical steroid responsive eczematous dermatoses. Pre- liminary report. Revista Brasileira de Medicina (1979) 36(6): 279–281.
   Google Scholar
• Stevanovic DV, Wilson L, Sparkes CG, A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate. British Journal of Dermatology (1977) 96(1): 67–70.
   PubMed Web of Science ®Google Scholar
• Woodbridge and Sparkes PA, Sparkes CG, Managing chronic skin conditions with two differing topical corticosteroids. Chronica Dermatologica (1979) 158: 299–306.
   Google Scholar
• Yamamoto K, Sasaki R, Fukuda, et al, Clobetasone 17 butyrate on atopic dermatitis in children. Journal of Paediatric Dermatology (1989) 8 (suppl.): 41– 487.
   Google Scholar
• Parneix-Spake A, Goustas P, Green R, Eumovate (Clobetasone butyrate) 0.05% cream with its moisturiz- ing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis. Journal of Dermatological Treatment (2001) 12: 191–197.
   PubMed Web of Science ®Google Scholar
• Munro DD, Wilson L, Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. British Medical Journal (1975) 3: 626– 628.
   PubMed Web of Science ®Google Scholar
• Black MM, Platt NE, Mugglestone CJ, A study of potential skin atrophy following topical application of weak corticosteroids. Current Medical Research and Opinion (1981) 7(7): 463–470.
   PubMed Web of Science ®Google Scholar
• Cornell RC, Atrophogenic potential of alclometasone dipropionate ointment 0.05% versus hydrocortisone ointment 1.0%. Current Therapeutic Research (1986) 39(2): 260–268.
   Web of Science ®Google Scholar
• James MP, Black MM, Sparkes CG, Measurement of dermal atrophy induced by topical steroids using a radiographic technique. British Journal of Dermatology (1977) 96: 303–305.
   PubMed Web of Science ®Google Scholar
• Tan CY, Marks R, Payne P, Comparison of xeroradio- graphic and ultrasound detection of corticosteroid induced dermal thinning. Journal of Investigative Derma- tology (1981) 76: 126–128.
   PubMed Web of Science ®Google Scholar
• Marks R, Dykes PJ, Roberts E, The measurements of corticosteroid induced dermal atrophy by a radiological method. Archives of Dermatological Research (1975) 253: 93–96.
   PubMedGoogle Scholar
• Kirby DJ, Munro DD, Steroid-induced atrophy in an animal and human model. British Journal of Dermatology (1976) 94 (suppl 12): 111–119.
   Google Scholar
• Ishi M, Kohno T, Kitajima JI, et al, Clinical evaluations of clobetasone 17 butyrate ointment (Kindavate) on the various facial dermatoses. Skin Research (1986) 28(1): 74–81.
   Google Scholar
• Dykes PJ, Marks R, The atrophogenicity of 1% hydro- cortisone plus 10% urea (Alphaderm). A comparison with other corticosteroids. Clinical Trials Journal (1977) 14(4): 139–144.
   Google Scholar
• Winter G, Burton JL, Experimentally induced steroid atrophy in the domestic pig and man. British Journal of Dermatology (1976) 94 (suppl 12): 107–109.
   Google Scholar
• Lee, Maibach JY, Maibach HI, Corticosteroid skin atrophogenicity assessment methods. Skin Research Technology (1998) 4: 161–166.
   PubMedGoogle Scholar
• Boner AL, Valletta EA, Richelli C, et al, Metabolic activity of systemic polymorphonucleated leucocytes (PMNs) in atopic children treated with clobetasone butyrate. Current Therapeutic Research (1985[c]) 37(1): 109–114.
   Google Scholar
• Quielle C, Pommarede R, Saurat J-H, Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Paediatric Dermatology (1984) 1(3): 246–253.
   PubMedGoogle Scholar
• Sparkes CG, Measuring adrenal function in out-patients using topical corticosteroids. British Journal of Dermatol- ogy (1976) 94 (suppl 12): 77–82.
   Google Scholar
• Wolkerstofer A, Strobos MA, Glazenburg EJ, et al, Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. J Am Acad Dermatol (1998) 39: 226–31.
   PubMed Web of Science ®Google Scholar
• Patel L, Clayton PE, Addison GM, et al, Adrenal function following topical steroid treatment in children with atopic dermatitis. British Journal of Dermatology (1995) 132: 950–955.
   PubMed Web of Science ®Google Scholar
• Ellison JA, Patel L, Ray DW, et al, Hypothalamic- pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics (2000) 105: 794–799.
   PubMed Web of Science ®Google Scholar
• Hehir M, du Vivier A, Eilon L, et al, Investigation of the pharmacokinetics of clobetasol propionate and clobeta- sone butyrate after a single application of ointment. Clinical and Experimental Dermatology (1983) 8: 143–151.
   PubMed Web of Science ®Google Scholar
• Patel L, Clayton PE, Jenney ME, et al, Adult height in patients with childhood onset atopic dermatitis. Archives of Disease in Childhood (1997) 76(6): 505–8.
   PubMed Web of Science ®Google Scholar
• Mygind H, Thulstrup AM, Pedersen L, et al, Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand (2002) 81: 234–9.
   PubMed Web of Science ®Google Scholar
• Long CC, Finlay AY, The fingertip unit: a new practical measure. Clin Exp Dermatol (1991) 16: 444–7.
   PubMed Web of Science ®Google Scholar
• Long CC, Mills CM, Finlay AY, A practical guide to topical therapy in children. British Journal of Dermatology (1998) 138: 293–296.
   PubMed Web of Science ®Google Scholar